MétaCan
Menu
← Back to cohort
Record W7117256215 · doi:10.1002/alz70858_100775

Understanding the patient voice for medicine development: Qualitative research of the patient journey in Alzheimer's Disease

2025· article· en· W7117256215 on OpenAlexaboutno aff
Chiko Ncube, Dave Pearce, Harjeet Dhillon, Joanna Culver, Robert Y. K. Lai

Bibliographic record

VenueAlzheimer s & Dementia · 2025
Typearticle
Languageen
FieldMedicine
TopicDementia and Cognitive Impairment Research
Canadian institutionsnot available
Fundersnot available
KeywordsDementiaQualitative researchDiseaseEthnic groupHealth careRace (biology)Alternative medicineFocus groupCognitive impairment

Abstract

fetched live from OpenAlex

Significant disparities exist throughout the patient journey and ultimately in health outcomes across diverse patient populations with Alzheimer's Disease (AD). The aim of this qualitative market research was to better understand the experiences of a diverse group of patients living with AD, to support inclusive and patient-centered approaches in medicine development. Patients diagnosed with mild cognitive impairment (MCI) and dementia due to AD (mild, moderate, or severe), and care partners of patients living with AD, were included in this research. Participants were interviewed one-to-one or as dyads, with follow-up ethnographic tasks. The research included a diverse group of patients across geography, ethnicity, race and employment status. Data was thematically analysed. A total of 65 participants (29 patients and 36 care partners) from the United States (US; 15%), Canada (20%), China (17%), France (12%), Germany (17%), and Italy (18%) were included. The mean patient age was 65.7 years, with the reported stage of disease as MCI or mild dementia due to AD (40%) and moderate or severe dementia due to AD (60%). The analysis revealed an overall consistent patient journey including diagnosis, day-to-day living, care, and treatment experiences. Some variations were revealed in the lived experiences of different patient groups. Many patients from diverse ethnic/racial groups emphasized the importance of family involvement in care and treatment decisions. Black participants in the US expressed concerns with seeking treatment due to lack of representation in medicine development and the need for future medications to be explicitly trialled in participants from ethnic/racial minorities. Asian participants in China, the US and Canada reported major stigma associated with AD, which delayed them in seeking medical help. Across all countries, patients living in rural locations experienced increased financial and logistical burden in accessing healthcare. These findings underscore the need to better understand the unique experiences faced by diverse populations of patients when considering the process for AD medicine development. A patient-centered approach could help increase trust and ultimately improve the patient experiences and health outcomes for diverse populations affected by AD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.034
metaresearch head score (Gemma)0.037
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Qualitative · Consensus signal: Qualitative
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.034
Threshold uncertainty score0.180

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0340.037
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0020.003
Science and technology studies0.0110.014
Scholarly communication0.0080.007
Open science0.0020.008
Research integrity0.0020.004
Insufficient payload (model declined to judge)0.0030.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.223
GPT teacher head0.446
Teacher spread0.223 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designQualitative
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & Dementia→Same topicDementia and Cognitive Impairment Research→French-language works237,207→